Environ Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 17 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 29.46%
(FY 2019)
- Profit -0.69%
(FY 2019)
- Ebitda 20.04%
(FY 2019)
- Net Worth -24.89%
(FY 2019)
- Total Assets -24.97%
(FY 2019)
About Environ Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kangaparambil Manoj, Paranganattu Pushpakaran, Aduparambil Sajeev, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233KL2007PTC021273
- Company No.
021273
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2007
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Environ Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kangaparambil Manoj  | Director | 04-Oct-2007 | Current |
| Paranganattu Pushpakaran | Director | 01-Nov-2013 | Current |
| Aduparambil Sajeev | Director | 16-Apr-2018 | Current |
| Sudeep Veeraraghavan | Additional Director | 12-Aug-2019 | Current |
Financial Performance of Environ Pharmaceuticals.
Environ Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 29.46% increase. The company also saw a slight decrease in profitability, with a 0.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Environ Pharmaceuticals?
In 2017, Environ Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uniswift Pharmaceuticals Private LimitedActive 5 years 1 monthKangaparambil Manoj is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Environ Pharmaceuticals?
Unlock and access historical data on people associated with Environ Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Environ Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Environ Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
